Dorota Bukowska

Dorota Bukowska

Auto-generated profile, based on publicly available information

Dorota Bukowska

Department of Diagnostics and Clinical Sciences, Institute of Veterinary Medicine, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MTMax Tschuschke
Max Tschuschke
IKIevgeniia Kocherova
Ievgeniia Kocherova
ABArtur Bryja
Artur Bryja
PMPaul Mozdziak
Paul Mozdziak
Ana Angelova VolponiAna Angelova Volponi
Ana Angelova Volponi
Bartosz KempistyBartosz Kempisty
Bartosz Kempisty
Exosomes are a heterogenous subpopulation of extracellular vesicles 30–150 nm in range and of endosome-derived origin. We explored the exosome formation through different systems, including the endosomal sorting complex required for transport (ESCRT) and ESCRT-independent system, looking at the mechanisms of release. Different isolation techniques and specificities of exosomes from different tissues and cells are also discussed. Despite more than 30 years of research that followed their definition and indicated their important role in cellular physiology, the exosome biology is still in its infancy with rapidly growing interest. The reasons for the rapid increase in interest with respect to exosome biology is because they provide means of intercellular communication and transmission of macromolecules between cells, with a potential role in the development of diseases. Moreover, they have been investigated as prognostic biomarkers, with a potential for further development as diagnostic tools for neurodegenerative diseases and cancer. The interest grows further with the fact that exosomes were reported as useful vectors for drugs.

3 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IKIevgeniia Kocherova
Ievgeniia Kocherova
ABArtur Bryja
Artur Bryja
PMPaul Mozdziak
Paul Mozdziak
Ana Angelova VolponiAna Angelova Volponi
Ana Angelova Volponi
Marta Dyszkiewicz KonwinskaMarta Dyszkiewicz Konwinska
Marta Dyszkiewicz Konwinska
Bartosz KempistyBartosz Kempisty
Bartosz Kempisty
The repair of bone defects caused by trauma, infection or tumor resection is a major clinical orthopedic challenge. The application of bone grafts in orthopedic procedures is associated with a problem of inadequate vascularization in the initial phase after implantation. Meanwhile, the survival of cells within the implanted graft and its integration with the host tissue is strongly dependent on nutrient and gaseous exchange, as well as waste product removal, which are effectuated by blood microcirculation. In the bone tissue, the vasculature also delivers the calcium and phosphate indispensable for the mineralization process. The critical role of vascularization for bone healing and function, led the researchers to the idea of generating a capillary-like network within the bone graft in vitro, which could allow increasing the cell survival and graft integration with a host tissue. New strategies for engineering pre-vascularized bone grafts, that apply the co-culture of endothelial and bone-forming cells, have recently gained interest. However, engineering of metabolically active graft, containing two types of cells requires deep understanding of the underlying mechanisms of interaction between these cells. The present review focuses on the best-characterized endothelial cells—human umbilical vein endothelial cells (HUVECs)—attempting to estimate whether the co-culture approach, using these cells, could bring us closer to development and possible clinical application of prevascularized bone grafts.

23 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
MKMagdalena Kulus
Magdalena Kulus
RSRafal Sibiak
Rafal Sibiak
KSKatarzyna Stefańska
Katarzyna Stefańska
MZMaciej Zdun
Maciej Zdun
MWMaria Wieczorkiewicz
Maria Wieczorkiewicz
Bartosz KempistyBartosz Kempisty
Bartosz Kempisty
Mesenchymal stem/stromal cells (MSCs) are currently one of the most extensively researched fields due to their promising opportunity for use in regenerative medicine. There are many sources of MSCs, of which cells of perinatal origin appear to be an invaluable pool. Compared to embryonic stem cells, they are devoid of ethical conflicts because they are derived from tissues surrounding the fetus and can be safely recovered from medical waste after delivery. Additionally, perinatal MSCs exhibit better self-renewal and differentiation properties than those derived from adult tissues. It is important to consider the anatomy of perinatal tissues and the general description of MSCs, including their isolation, differentiation, and characterization of different types of perinatal MSCs from both animals and humans (placenta, umbilical cord, amniotic fluid). Ultimately, signaling pathways are essential to consider regarding the clinical applications of MSCs. It is important to consider the origin of these cells, referring to the anatomical structure of the organs of origin, when describing the general and specific characteristics of the different types of MSCs as well as the pathways involved in differentiation.

4 January 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GHGreg Hutchings
Greg Hutchings
LMLisa Moncrieff
Lisa Moncrieff
CDClaudia Dompe
Claudia Dompe
KJKrzysztof Janowicz
Krzysztof Janowicz
RSRafal Sibiak
Rafal Sibiak
Hanna Piotrowska-KempistyHanna Piotrowska-Kempisty
Hanna Piotrowska-Kempisty
The deterioration of the human skeleton’s capacity for self-renewal occurs naturally with age. Osteoporosis affects millions worldwide, with current treatments including pharmaceutical agents that target bone formation and/or resorption. Nevertheless, these clinical approaches often result in long-term side effects, with better alternatives being constantly researched. Mesenchymal stem cells (MSCs) derived from bone marrow and adipose tissue are known to hold therapeutic value for the treatment of a variety of bone diseases. The following review summarizes the latest studies and clinical trials related to the use of MSCs, both individually and combined with other methods, in the treatment of a variety of conditions related to skeletal health. For example, some of the most recent works noted the advantage of bone grafts based on biomimetic scaffolds combined with MSC and growth factor delivery, with a greatly increased regeneration rate and minimized side effects for patients. This review also highlights the continuing research into the mechanisms underlying bone homeostasis, including the key transcription factors and signalling pathways responsible for regulating the differentiation of osteoblast lineage. Paracrine factors and specific miRNAs are also believed to play a part in MSC differentiation. Furthering the understanding of the specific mechanisms of cellular signalling in skeletal remodelling is key to incorporating new and effective treatment methods for bone disease.

16 March 2024 in Nanomaterials
Verified
Journal Article
Open access
PDF file
TGTomasz Górnicki
Tomasz Górnicki
JLJakub Lambrinow
Jakub Lambrinow
ANAfsaneh Golkar Narenji
Afsaneh Golkar Narenji
KDKrzysztof Piotr Data
Krzysztof Piotr Data
DDDominika Maria Domagała
Dominika Maria Domagała
Bartosz KempistyBartosz Kempisty
Bartosz Kempisty
Biomimetic scaffolds imitate native tissue and can take a multidimensional form. They are biocompatible and can influence cellular metabolism, making them attractive bioengineering platforms. The use of biomimetic scaffolds adds complexity to traditional cell cultivation methods. The most commonly used technique involves cultivating cells on a flat surface in a two-dimensional format due to its simplicity. A three-dimensional (3D) format can provide a microenvironment for surrounding cells. There are two main techniques for obtaining 3D structures based on the presence of scaffolding. Scaffold-free techniques consist of spheroid technologies. Meanwhile, scaffold techniques contain organoids and all constructs that use various types of scaffolds, ranging from decellularized extracellular matrix (dECM) through hydrogels that are one of the most extensively studied forms of potential scaffolds for 3D culture up to 4D bioprinted biomaterials. 3D bioprinting is one of the most important techniques used to create biomimetic scaffolds. The versatility of this technique allows the use of many different types of inks, mainly hydrogels, as well as cells and inorganic substances. Increasing amounts of data provide evidence of vast potential of biomimetic scaffolds usage in tissue engineering and personalized medicine, with the main area of potential application being the regeneration of skin and musculoskeletal systems. Recent papers also indicate increasing amounts of in vivo tests of products based on biomimetic scaffolds, which further strengthen the importance of this branch of tissue engineering and emphasize the need for extensive research to provide safe for humansbiomimetic tissues and organs. In this review article, we provide a review of the recent advancements in the field of biomimetic scaffolds preceded by an overview of cell culture technologies that led to the development of biomimetic scaffold techniques as the most complex type of cell culture.

18 January 2023 in Cells
Verified
Journal Article
Open access
PDF file
KSKatarzyna Stefańska
Katarzyna Stefańska
MJMałgorzata Józkowiak
Małgorzata Józkowiak
Ana Angelova VolponiAna Angelova Volponi
Ana Angelova Volponi
Jamil Awad ShibliJamil Awad Shibli
Jamil Awad Shibli
ANAfsaneh Golkar Narenji
Afsaneh Golkar Narenji
Bartosz KempistyBartosz Kempisty
Bartosz Kempisty
Exosomes are biological nanoscale spherical lipid bilayer vesicles, 40–160 nm in diameter, produced by most mammalian cells in both physiological and pathological conditions. Exosomes are formed via the endosomal sorting complex required for transport (ESCRT). The primary function of exosomes is mediating cell-to-cell communication. In terms of cancer, exosomes play important roles as mediators of intercellular communication, leading to tumor progression. Moreover, they can serve as biomarkers for cancer detection and progression. Therefore, their utilization in cancer therapies has been suggested, either as drug delivery carriers or as a diagnostic tool. However, exosomes were also reported to be involved in cancer drug resistance via transferring information of drug resistance to sensitive cells. It is important to consider the current knowledge regarding the role of exosomes in cancer, drug resistance, cancer therapies, and their clinical application in cancer therapies.